These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection. Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245 [TBL] [Abstract][Full Text] [Related]
4. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20. Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004 [TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2. Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection. Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207 [TBL] [Abstract][Full Text] [Related]
7. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection. Bernelin-Cottet C; Urien C; Fretaud M; Langevin C; Trus I; Jouneau L; Blanc F; Leplat JJ; Barc C; Boulesteix O; Riou M; Dysart M; Mahé S; Studsrub E; Nauwynck H; Bertho N; Bourry O; Schwartz-Cornil I Viruses; 2019 Jun; 11(6):. PubMed ID: 31242645 [TBL] [Abstract][Full Text] [Related]
8. A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: A proof of concept. Suradhat S; Wongyanin P; Kesdangsakonwut S; Teankum K; Lumyai M; Triyarach S; Thanawongnuwech R Vaccine; 2015 Jul; 33(32):3997-4003. PubMed ID: 26079617 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs. Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738 [TBL] [Abstract][Full Text] [Related]
10. A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus. Bernelin-Cottet C; Urien C; Stubsrud E; Jakob V; Bouguyon E; Bordet E; Barc C; Boulesteix O; Contreras V; Barnier-Quer C; Collin N; Trus I; Nauwynck H; Bertho N; Schwartz-Cornil I Viruses; 2019 Jun; 11(6):. PubMed ID: 31207934 [TBL] [Abstract][Full Text] [Related]
11. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1. Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335 [TBL] [Abstract][Full Text] [Related]
12. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus. Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1). Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048 [TBL] [Abstract][Full Text] [Related]
14. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery. Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289 [TBL] [Abstract][Full Text] [Related]
15. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV. Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103 [TBL] [Abstract][Full Text] [Related]
16. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus. Pujhari S; Baig TT; Hansra S; Zakhartchouk AN Virus Res; 2013 May; 173(2):321-6. PubMed ID: 23353778 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420 [TBL] [Abstract][Full Text] [Related]
18. Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus. Díaz I; Gimeno M; Callén A; Pujols J; López S; Charreyre C; Joisel F; Mateu E Vet J; 2013 Aug; 197(2):438-44. PubMed ID: 23499541 [TBL] [Abstract][Full Text] [Related]
19. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant. Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162 [TBL] [Abstract][Full Text] [Related]
20. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction. Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]